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Antiidiotypic antibodies against a platelet reactive IgG Fab cloned from a combinatorial 
antibody library of a healthy individual 
 
Since many years, intravenously administered IgG antibodies (IVIG) prepared from plasma 
of numerous healthy blood donors are successfully used in the therapy of autoimmune 
thrombocytopenia (AITP) and other autoimmune diseases. IVIG`s mechanism of action  
seems to be complex and is not clearly clarified yet. Both Fc-receptor dependent effects and 
immunmodulatory antiidiotypic effects based on the antigen-binding sites, the so called Fab 
fragments, were discussed to play a role.  
Applying phage display and antiidiotypic biopanning with IVIG to investigate the antiidiotypic 
effects of IVIG on the immune system, the group of PD Dr. Peter Fischer had cloned and 
characterized many platelet reactive human IgG Fab fragments from patients with AITP for 
the first time. The platelet reactive Fab fragments originated predominantly from the VH-4 
germline gene family. However, the VH germline genes 3-23 and 3-30 represented the most 
frequent genetic origin of the variable region of the heavy chain regarding the platelet-
negative, IVIG selected clones from autoimmune patients and from a healthy individual. 
Interestingly, the CDR3-region and the light chains seemed to have no influence on the 
selection by IVIG, likewise there was no accumulation of certain DH- and JH-germline genes. 
The fact that IVIG preferably bound antibodies originating from the germline gene segments 
3-30 and 3-23 independent of a certain disease together with other results suggested a 
fundamental meaning of these interaction for the regulation of the B-cell repertoire. This led 
to the hypothesis that IVIG may regulate the B-cell repertoire over a B-cell-superantigen-like-
function besides the direct binding of autoantibodies.  
 
In order to get more information about the potential regulating molecules of IVIG and to reach 
a possible clinical relevance it was the goal of this study to clone the therapeutically relevant 
molecules from IVIG. For that purpose the IVIG-targets described above and a Fab-Phage-
library of a healthy donor (as representative for IVIG) which were already established by the 
group of PD Dr. Peter Fischer should be used. The structural and functional characterisation 
of the isolated clones afterwards should made the possible antiidiotypic mechanism of IVIG 
more clear. 
 
Fab presenting phage clones originating from an IgG library of a healthy individual and 
isolated by binding to a platelet reactive Fab fragment of the VH 3-30 gene family (LO31) 
isolated previously with IVIG could be cloned by means of phage display and biopanning 
technique.  
Sequencing of four LO31-binding Fab phage clones, which displayed a different BstNI 
restriction pattern, revealed the genetic identity of three clones originating from VH4-61 and 
VL2a2. The fourth clone showed a VH1-02 and VL2a2 germline gene origin. 
When sequences were compared at DNA and protein level a great variability of the CDRs as 
well as framework regions was revealed. The CDRs not only differed in their amino-acid 
patterns but also partially in their length. Determination of mutation rates from CDRs and 





and silent mutations led to the conclusion that mutations of the germline genes were antigen 
driven.  
 
To characterise the binding properties of the LO31 binding Fab phages, soluble Fab 
fragments with differing binding specificities and partially differing genetic origin were large-
scale produced and purified. Subsequent binding assays demonstrated that isolated Fab 
phages bound specifically to the Fab fragments by which they had been isolated. Other Fab 
fragments bound only weak or not at all. Binding to Fc fragment was not detectable. As a 
result, the isolated Fab fragments did not bind multiple VH3-30 or VH3-23 originating 
antibodies but were true antiidiotypic antibodies against a single antibody. 
In conclusion, two Fab fragments which interact highly specifically/antiidiotypically with a 
single IVIG-selected Fab were successfully isolated from an IgG library of a healthy 
individual. They did not represent the postulated subset from IVIG, representing a B cell 
superantigen, which binds outside of the antigen binding site to multiple B-cell receptors, but 
refers to antibodies, which - as individual idiotyps – bind rather as Ab2 beta or gamma. The 
reason may have been the very restricted panning procedures. The isolated Fab fragments 
might represent antibodies from IVIG with thrombocyte autoantibody-blocking properties and 
hence inhibit the autoantibody caused destruction of the thrombocytes. 
 
 
 
 
